Palbociclib and Dexamethasone in Treating Participants With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia

Clinical trial NCT03472573 · COMPLETED

Trial details

NCT number: NCT03472573
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent B Acute Lymphoblastic Leukemia Refractory B Acute Lymphoblastic Leukemia

Start date: 2018-05-09
Primary completion: 2021-08-04
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.